nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolterodine—Labetalol—ADRB3—polycystic ovary syndrome	0.0115	0.725	CrCbGaD
Tolterodine—CYP2C19—urine—polycystic ovary syndrome	0.00993	0.165	CbGeAlD
Tolterodine—CYP2C9—urine—polycystic ovary syndrome	0.0077	0.128	CbGeAlD
Tolterodine—CYP3A4—urine—polycystic ovary syndrome	0.00587	0.0977	CbGeAlD
Tolterodine—CYP2D6—urine—polycystic ovary syndrome	0.00578	0.0961	CbGeAlD
Tolterodine—Labetalol—ADRB2—polycystic ovary syndrome	0.00438	0.276	CrCbGaD
Tolterodine—CHRM3—adipose tissue—polycystic ovary syndrome	0.00228	0.0379	CbGeAlD
Tolterodine—KCNH2—endometrium—polycystic ovary syndrome	0.00224	0.0373	CbGeAlD
Tolterodine—CHRM2—endocrine gland—polycystic ovary syndrome	0.00218	0.0362	CbGeAlD
Tolterodine—KCNH2—uterus—polycystic ovary syndrome	0.00207	0.0343	CbGeAlD
Tolterodine—KCNH2—pituitary gland—polycystic ovary syndrome	0.00203	0.0337	CbGeAlD
Tolterodine—CHRM1—endocrine gland—polycystic ovary syndrome	0.00198	0.0329	CbGeAlD
Tolterodine—CHRM3—female gonad—polycystic ovary syndrome	0.00191	0.0317	CbGeAlD
Tolterodine—KCNH2—adrenal gland—polycystic ovary syndrome	0.00181	0.0301	CbGeAlD
Tolterodine—CHRM3—endocrine gland—polycystic ovary syndrome	0.00177	0.0295	CbGeAlD
Tolterodine—CYP2C19—vagina—polycystic ovary syndrome	0.00176	0.0293	CbGeAlD
Tolterodine—KCNH2—female gonad—polycystic ovary syndrome	0.00169	0.0281	CbGeAlD
Tolterodine—KCNH2—vagina—polycystic ovary syndrome	0.00168	0.0279	CbGeAlD
Tolterodine—CYP2C19—endocrine gland—polycystic ovary syndrome	0.00165	0.0274	CbGeAlD
Tolterodine—KCNH2—endocrine gland—polycystic ovary syndrome	0.00157	0.0261	CbGeAlD
Tolterodine—CYP2C9—endocrine gland—polycystic ovary syndrome	0.00128	0.0212	CbGeAlD
Tolterodine—CYP2D6—female gonad—polycystic ovary syndrome	0.00103	0.0171	CbGeAlD
Tolterodine—CYP3A4—endocrine gland—polycystic ovary syndrome	0.000974	0.0162	CbGeAlD
Tolterodine—CYP2D6—endocrine gland—polycystic ovary syndrome	0.000958	0.0159	CbGeAlD
Tolterodine—CHRM5—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000145	0.000157	CbGpPWpGaD
Tolterodine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000145	0.000157	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000145	0.000157	CbGpPWpGaD
Tolterodine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000145	0.000156	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000144	0.000156	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000144	0.000156	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000143	0.000155	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000143	0.000155	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—CYP17A1—polycystic ovary syndrome	0.000143	0.000155	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000143	0.000155	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—PRL—polycystic ovary syndrome	0.000143	0.000155	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—HSD3B1—polycystic ovary syndrome	0.000142	0.000154	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000142	0.000153	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.00014	0.000152	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000138	0.000149	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000138	0.000149	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000137	0.000148	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	0.000137	0.000148	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—PRL—polycystic ovary syndrome	0.000137	0.000148	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000136	0.000147	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	0.000136	0.000147	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000136	0.000147	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000135	0.000147	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000134	0.000145	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000134	0.000145	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000134	0.000145	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000133	0.000144	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	0.000133	0.000143	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	0.000133	0.000143	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000132	0.000143	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000132	0.000143	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	0.000131	0.000141	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.00013	0.00014	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—LHB—polycystic ovary syndrome	0.00013	0.00014	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	0.00013	0.00014	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000128	0.000139	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000128	0.000139	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—INSR—polycystic ovary syndrome	0.000128	0.000138	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—HSD3B2—polycystic ovary syndrome	0.000127	0.000137	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—INSR—polycystic ovary syndrome	0.000127	0.000137	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000126	0.000136	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—TH—polycystic ovary syndrome	0.000124	0.000134	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—AKR1C1—polycystic ovary syndrome	0.000123	0.000133	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000122	0.000132	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000121	0.000131	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000121	0.000131	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—SLC2A4—polycystic ovary syndrome	0.00012	0.00013	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—GNAS—polycystic ovary syndrome	0.00012	0.00013	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.00012	0.00013	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.00012	0.00013	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.00012	0.00013	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.00012	0.000129	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	0.000119	0.000129	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000119	0.000128	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000118	0.000128	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—PGR—polycystic ovary syndrome	0.000118	0.000128	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	0.000118	0.000128	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000117	0.000127	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—PGR—polycystic ovary syndrome	0.000117	0.000127	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	0.000116	0.000126	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	0.000115	0.000125	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000115	0.000124	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—CYP19A1—polycystic ovary syndrome	0.000113	0.000122	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—SULT2A1—polycystic ovary syndrome	0.000113	0.000122	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	0.000113	0.000122	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000112	0.000122	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	0.000112	0.000121	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	0.000111	0.00012	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.00011	0.000119	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.00011	0.000119	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—PLAT—polycystic ovary syndrome	0.00011	0.000119	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—GHRL—polycystic ovary syndrome	0.00011	0.000119	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—RRM2—polycystic ovary syndrome	0.000109	0.000118	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000109	0.000118	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000109	0.000118	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000106	0.000115	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000106	0.000115	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—YAP1—polycystic ovary syndrome	0.000105	0.000114	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	0.000105	0.000114	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000105	0.000114	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000105	0.000114	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000105	0.000114	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000104	0.000112	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	0.000104	0.000112	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	0.000103	0.000111	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000103	0.000111	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000102	0.000111	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000102	0.000111	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000102	0.00011	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000101	0.00011	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—NAMPT—polycystic ovary syndrome	0.000101	0.00011	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—GNAS—polycystic ovary syndrome	0.000101	0.000109	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000101	0.000109	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000101	0.000109	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000101	0.000109	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	0.000101	0.000109	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	0.0001	0.000109	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—CYP11A1—polycystic ovary syndrome	0.0001	0.000108	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	9.97e-05	0.000108	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	9.92e-05	0.000107	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—LEP—polycystic ovary syndrome	9.85e-05	0.000107	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—NGFR—polycystic ovary syndrome	9.72e-05	0.000105	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	9.69e-05	0.000105	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—NGFR—polycystic ovary syndrome	9.68e-05	0.000105	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—POMC—polycystic ovary syndrome	9.65e-05	0.000104	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—IRS2—polycystic ovary syndrome	9.64e-05	0.000104	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—PRL—polycystic ovary syndrome	9.63e-05	0.000104	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—POMC—polycystic ovary syndrome	9.62e-05	0.000104	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—NCOR1—polycystic ovary syndrome	9.62e-05	0.000104	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	9.61e-05	0.000104	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—PRL—polycystic ovary syndrome	9.6e-05	0.000104	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—NGFR—polycystic ovary syndrome	9.59e-05	0.000104	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—POMC—polycystic ovary syndrome	9.53e-05	0.000103	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—PRL—polycystic ovary syndrome	9.51e-05	0.000103	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—AKR1C3—polycystic ovary syndrome	9.44e-05	0.000102	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—LEP—polycystic ovary syndrome	9.43e-05	0.000102	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	9.31e-05	0.000101	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—CYP17A1—polycystic ovary syndrome	9.29e-05	0.000101	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—AKT2—polycystic ovary syndrome	9.28e-05	0.0001	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—AKT2—polycystic ovary syndrome	9.25e-05	0.0001	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	9.23e-05	9.99e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	9.19e-05	9.95e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	9.18e-05	9.93e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—AKT2—polycystic ovary syndrome	9.16e-05	9.91e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—ADRB2—polycystic ovary syndrome	9.13e-05	9.89e-05	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—CYP1A1—polycystic ovary syndrome	9.12e-05	9.87e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	9.11e-05	9.86e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—ADRB2—polycystic ovary syndrome	9.11e-05	9.86e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	9.05e-05	9.79e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—ADRB2—polycystic ovary syndrome	9.02e-05	9.76e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	8.95e-05	9.69e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—IRS1—polycystic ovary syndrome	8.78e-05	9.51e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	8.68e-05	9.4e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	8.61e-05	9.32e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	8.55e-05	9.25e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	8.54e-05	9.25e-05	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—MTHFR—polycystic ovary syndrome	8.5e-05	9.2e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	8.47e-05	9.17e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—GNAS—polycystic ovary syndrome	8.47e-05	9.17e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—POMC—polycystic ovary syndrome	8.46e-05	9.15e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—GNAS—polycystic ovary syndrome	8.44e-05	9.14e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—IRS1—polycystic ovary syndrome	8.41e-05	9.1e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—INS—polycystic ovary syndrome	8.41e-05	9.1e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—GNAS—polycystic ovary syndrome	8.36e-05	9.05e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—IGF1—polycystic ovary syndrome	8.14e-05	8.81e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—AKT2—polycystic ovary syndrome	8.13e-05	8.8e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—POMC—polycystic ovary syndrome	8.1e-05	8.77e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—NCOR1—polycystic ovary syndrome	8.07e-05	8.73e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—INS—polycystic ovary syndrome	8.06e-05	8.72e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—NCOR1—polycystic ovary syndrome	8.04e-05	8.71e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—TH—polycystic ovary syndrome	8.04e-05	8.7e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—NCOR1—polycystic ovary syndrome	7.97e-05	8.62e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—NRG1—polycystic ovary syndrome	7.92e-05	8.57e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—NRG1—polycystic ovary syndrome	7.9e-05	8.54e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—SLC2A4—polycystic ovary syndrome	7.82e-05	8.47e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—NRG1—polycystic ovary syndrome	7.82e-05	8.46e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—IGF1—polycystic ovary syndrome	7.79e-05	8.43e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	7.79e-05	8.43e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—AKT2—polycystic ovary syndrome	7.79e-05	8.43e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—SERPINE1—polycystic ovary syndrome	7.73e-05	8.36e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	7.61e-05	8.24e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—SERPINE1—polycystic ovary syndrome	7.4e-05	8.01e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—TH—polycystic ovary syndrome	7.4e-05	8e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	7.37e-05	7.98e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—CYP19A1—polycystic ovary syndrome	7.35e-05	7.96e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—TH—polycystic ovary syndrome	7.33e-05	7.94e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	7.19e-05	7.79e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	7.13e-05	7.72e-05	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—PPARG—polycystic ovary syndrome	6.89e-05	7.46e-05	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—POMC—polycystic ovary syndrome	6.8e-05	7.36e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	6.79e-05	7.34e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—IRS2—polycystic ovary syndrome	6.78e-05	7.34e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	6.76e-05	7.32e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—IRS2—polycystic ovary syndrome	6.76e-05	7.32e-05	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—INS—polycystic ovary syndrome	6.76e-05	7.32e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	6.71e-05	7.26e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—IRS2—polycystic ovary syndrome	6.7e-05	7.25e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—LEP—polycystic ovary syndrome	6.64e-05	7.19e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—LEP—polycystic ovary syndrome	6.62e-05	7.16e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	6.57e-05	7.11e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—GNAS—polycystic ovary syndrome	6.56e-05	7.1e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—LEP—polycystic ovary syndrome	6.55e-05	7.09e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	6.34e-05	6.86e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—NCOR1—polycystic ovary syndrome	6.25e-05	6.77e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—IL6—polycystic ovary syndrome	6.22e-05	6.73e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	6.09e-05	6.59e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	6.04e-05	6.53e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	6.01e-05	6.51e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	5.99e-05	6.48e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—IL6—polycystic ovary syndrome	5.96e-05	6.45e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—CYP1A1—polycystic ovary syndrome	5.93e-05	6.42e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—IRS1—polycystic ovary syndrome	5.92e-05	6.41e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—IRS1—polycystic ovary syndrome	5.9e-05	6.39e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—IRS1—polycystic ovary syndrome	5.85e-05	6.33e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	5.75e-05	6.22e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—POMC—polycystic ovary syndrome	5.7e-05	6.17e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	5.7e-05	6.17e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—POMC—polycystic ovary syndrome	5.69e-05	6.15e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	5.68e-05	6.14e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—INS—polycystic ovary syndrome	5.67e-05	6.14e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—INS—polycystic ovary syndrome	5.65e-05	6.12e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—POMC—polycystic ovary syndrome	5.63e-05	6.09e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—INS—polycystic ovary syndrome	5.6e-05	6.06e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	5.59e-05	6.05e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—MTHFR—polycystic ovary syndrome	5.53e-05	5.98e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—IGF1—polycystic ovary syndrome	5.49e-05	5.94e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—AKT2—polycystic ovary syndrome	5.48e-05	5.93e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—IGF1—polycystic ovary syndrome	5.47e-05	5.92e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—AKT2—polycystic ovary syndrome	5.46e-05	5.91e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	5.45e-05	5.9e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—IGF1—polycystic ovary syndrome	5.42e-05	5.86e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—AKT2—polycystic ovary syndrome	5.41e-05	5.86e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	5.41e-05	5.85e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.31e-05	5.75e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.21e-05	5.64e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.19e-05	5.62e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.14e-05	5.57e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.09e-05	5.51e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	5.08e-05	5.5e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	5.04e-05	5.45e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—TH—polycystic ovary syndrome	4.84e-05	5.23e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	4.7e-05	5.09e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—PPARG—polycystic ovary syndrome	4.48e-05	4.85e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	4.42e-05	4.79e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—POMC—polycystic ovary syndrome	4.42e-05	4.78e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—INS—polycystic ovary syndrome	4.4e-05	4.76e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—IL6—polycystic ovary syndrome	4.2e-05	4.54e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—IL6—polycystic ovary syndrome	4.18e-05	4.53e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—IL6—polycystic ovary syndrome	4.14e-05	4.48e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	4.12e-05	4.46e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	4.09e-05	4.42e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	4.07e-05	4.4e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—INS—polycystic ovary syndrome	4.04e-05	4.38e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	4.03e-05	4.36e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—INS—polycystic ovary syndrome	4.01e-05	4.34e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	3.95e-05	4.27e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	3.76e-05	4.07e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—IL6—polycystic ovary syndrome	3.68e-05	3.98e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.58e-05	3.88e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.57e-05	3.87e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	3.56e-05	3.86e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.54e-05	3.83e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—IL6—polycystic ovary syndrome	3.52e-05	3.81e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	3.32e-05	3.6e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	2.69e-05	2.92e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	2.66e-05	2.88e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—INS—polycystic ovary syndrome	2.64e-05	2.86e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—IL6—polycystic ovary syndrome	2.48e-05	2.68e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—IL6—polycystic ovary syndrome	2.47e-05	2.67e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—IL6—polycystic ovary syndrome	2.45e-05	2.65e-05	CbGpPWpGaD
